Hyperthyroidism during GTD has been attributed to multiple pathways, e.g., via the stimulatory effect of hCG on the TSH receptor and high thyrotropic activity of basic hCG isoforms with less sialic acid in cases of chemoresistance or GTN progression/recurrence (with elevation of hCG levels). The gene discussed is TSHR; the disease is hyperthyroidism.